Contamination Risks Spark Recall of Products From Three Compounding Pharmacies
September 3rd, 2013|
September 3, 2013
Last week, the U.S. Food and Drug Administration (FDA) announced it was issuing recalls on products manufactured at three different compounding facilities due to lack of sterility assurance. The Alabama Drug Injury Lawyers with Norris Injury Lawyers explain the string of recalls comes on the heels of a fungal meningitis outbreak that claimed dozens of lives and left hundreds of others sickened.
An FDA press release announced a recall on six specific medications manufactured by Wellness Pharmacy, Inc., in Birmingham on Friday. Reports indicate that investigators were conducting an inspection of the facility when they discovered practices that may have compromised the sterility of certain medications. The following day, similar discoveries were made at facilities in Loveland, Colorado, and Irvine, California.
Anyone in possession of the products affected by these three recalls have been instructed to halt use of the medications immediately and contact the FDA’s MedWatch program to report adverse health events associated with the affected products.
So far, nearly one dozen compounding facilities have faced similar scrutiny in the past several months over sterile manufacturing procedures.
Norris Injury Lawyers’ team of Alabama Personal Injury Lawyers recognizes the dangers using a potentially contaminated medication could have. That is why the firm would encourage anyone who has been injured by a recalled drug to discuss their legal rights with an attorney immediately.